Loading clinical trials...
Loading clinical trials...
Reduction or Discontinuation of Calcineurine Inhibitors With Conversion to Everolimus-Based Immunosuppresion to Alleviate Chronic Allograft Nephropathy (CAN) in Kidney Transplant Recipients: A Prospective Randomized Study
Conditions
Interventions
adding Certican to therapy
reducing Tacrolimus
Locations
1
Israel
Transplantation department, rabin Medical Center
Petah Tikva, Israel
Start Date
February 1, 2007
Completion Date
February 1, 2010
Last Updated
March 6, 2007
NCT06656988
NCT04592640
NCT07094906
NCT07358572
NCT05099770
NCT06927024
Lead Sponsor
Rabin Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions